| Identification | |
| Name: | Rifamycin,3-[[[4-(2-methylpropyl)-1-piperazinyl]imino]methyl]- |
| Synonyms: | Rifamdin;Rifordin; |
| CAS: | 89499-17-2 |
| Molecular Formula: | C46H64N4O12 |
| Molecular Weight: | 865.02 |
| InChI: | InChI=1/C46H64N4O12/c1-23(2)22-49-16-18-50(19-17-49)47-21-31-36-41(56)34-33(40(31)55)35-43(29(8)39(34)54)62-46(10,44(35)57)60-20-15-32(59-11)26(5)42(61-30(9)51)28(7)38(53)27(6)37(52)24(3)13-12-14-25(4)45(58)48-36/h12-15,20-21,23-24,26-28,32,37-38,42,47,52-54,56H,16-19,22H2,1-11H3,(H,48,58)/b13-12+,20-15+,25-14+,31-21+ |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | °C |
| Boiling Point: | °Cat760mmHg |
| Density: | 1.31 g/cm3 |
| Refractive index: | 1.618 |
| Flash Point: | °C |
| Usage: | A Rifamicyn derivative with therapeutic effect on pulmonary tuberculosis |
| Safety Data | |
 |
|
